Win Non-Dilutive Funding
The FreeMind Group specializes in assisting life science organizations secure non-dilutive funding from US federal agencies and private foundations to fund R&D
Maximize your funding potential
We turn non-dilutive funding into a strategic source of funding for life science organizations
Professional Process
Supported by a suite of custom built AI tools, FreeMind has perfected a methodical approach to successful grant writing
Tap into +$70B non-dilutive funding market
Win R&D grants and contracts for the life sciences from agencies such as the NIH, DOD, BARDA, FDA, NSF etc.
CEOs Choose
“Working with FreeMind has been one of our best decisions yet. With less time needed for grant applications, as well as better quality submissions with better odds of getting funded, we have more time and resources to focus on R&D-precious commodities for a small biotech company trying to do great things.”
“FreeMind shepherded two organizations in two different countries through the grant application process and helped us get a US Department of Defense grant for our new cancer drug. What FreeMind does best is manage the process and keep everyone on target.”
“Non-dilutive grant funding has been instrumental in growing Abalone Bio’s platform technology and programs. A key element in our grant funding success has been working with FreeMind. We were paired with a fantastic grant writer who worked well with our team’s work cadence and high scientific and writing standards. I recommend FMG for groups wanting to maximize their grant funding success.”
“The people at FreeMind are excellent at finding US grants that suit the profile of our programs – and they do a great job managing the application process, providing solid guidance on how to tailor the applications to the grant objectives, and allowing our team to focus on the R&D parts of the documents. I can highly recommend working with FreeMind.”
“Working with FreeMind has been effective, efficient, and made what would otherwise been an incredibly stressful process well organized and seamless. They have been a strong partner for us, and I would highly recommend them, to any young company trying to break into non-dilutive funding. I can truly say, that we would not have been successful without their experience and strategic advice to guide us.”
Meet our strategic partners
The FreeMind Group partners across the life sciences with leading organizations in support of our growing community
FreeMind Supported Events
LSX Nordic Congress, October 8-9, 2024, Copenhagen, Denmark
Cell & Gene on the Mesa, October 7-9, 2024, Phoenix, AZ
LSX RNA Leaders, September 4-5, 2024, San Diego
LSX World Congress USA, September 11-12, 2024, Boston
The MedTech Conference, October 15-17, Toronto
BioFuture, October 28-30, 2024, NYC
Sachs Associates Oncology Innovation Forum, May 31, 2024, Chicago
RESI Europe, June 17, 2024, Barcelona
Equity Investments
FreeMind Investments is a novel investment platform developed by the FreeMind Group, and fund established in partnership with Daewoong Pharmaceuticals